Table 1

Characteristics by in-hospital mortality

FactorAll patients
N=51
Discharged alive
N=40
Died in-hospital
N=11
Univariate analysis p value*
Age ≥53 years, n (%)24 (47.1)16 (40.0)8 (72.7)0.05
Male, n (%)31 (60.8)26 (65.0)5 (45.5)0.24
Oceanic†, n (%)43 (84.3)34 (85.0)9 (81.8)0.80
Charlson's score >3, n (%)20 (39.2)13 (32.5)7 (63.4)0.08
Chronic renal replacement therapy, n (%)3 (5.9)2 (5.0)1 (9.1)0.61
Left-sided IE, n (%)47 (92.2)37 (92.5)10 (90.9)0.86
Native valve IE, n (%)34 (66.7)27 (67.5)7 (63.6)0.81
Aetiology of valve disease, n (%)0.17
 Rheumatic heart disease19 (37.2)17 (42.5)2 (18.2)
 Degenerative12 (23.5)7 (17.5)5 (45.5)
 Congenital6 (11.8)5 (12.5)1 (9.1)
 Functional2 (3.9)2 (5.0)0
Healthcare-related IE, n (%)8 (15.7)6 (15.0)2 (18.2)0.80
Microbiology, n (%)
Streptococcus spp15 (29.4)12 (30.0)3 (27.3)0.86
Staphylococcus aureus16 (31.4)12 (30.0)4 (36.4)0.69
Acute heart failure, n (%)17 (33.3)13 (32.5)4 (36.4)0.81
Severe valve regurgitation, n (%)15 (29.4)13 (32.5)2 (18.2)0.33
Neurological complication, n (%)23 (45.1)18 (45.0)5 (45.5)0.87
Shock, n (%)7 (13.7)2 (5.0)5 (45.5)<0.01
Vegetation length ≥15 mm, n (%)10 (19.6)7 (17.5)3 (27.3)0.39
Perivalvular abscess‡, n (%)5 (9.8)4 (10.0)1 (9.1)0.94
Cardiac surgery, n (%)22 (43.1)20 (50.0)2 (18.2)0.06
Cardiac surgery denied§, n (%)19 (37.3)12 (30.0)7 (63.8)0.04
  • *Comparison of patients discharged alive versus patients who died during their first hospital admission.

  • †Includes indigenous Melanesians and Polynesians.

  • ‡On echocardiography.

  • §In spite of at least one indication according to guidelines at the time of treatment.

  • IE, infective endocarditis.